Last reviewed · How we verify

NCT03479073

Risk Factors of Stroke or Systemic Embolism After Atrial Fibrillation Ablation

Completed Last updated 18 June 2018
What this trial tests

trial in Atrial Fibrillation in 3,198 participants. Completed in 14 June 2018.

Timeline
17 May 2017
Primary endpoint
14 June 2018
14 June 2018

Quick facts

Lead sponsorKorea University Guro Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment3,198
Start date17 May 2017
Primary completion14 June 2018
Estimated completion14 June 2018
Sites3 locations across South Korea

Conditions studied

Sponsor

Korea University Guro Hospital

Who can join

Eligibility, any sex, with Atrial Fibrillation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To investigate the rate and risk factors of stroke or systemic embolism (SE) following atrial fibrillation (AF) ablation.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Association between epicardial adipose tissue and embolic stroke after catheter ablation of atrial fibrillation.
    Ahn J, Shin SY, Shim J, Kim YH, et al · · 2019 · cited 11× · PMID 31502330 · DOI 10.1111/jce.14154

Verify or expand the search:

Other recruiting trials for Atrial Fibrillation

Currently open trials in the same condition.

Other Korea University Guro Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03479073.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing